Schonfeld Strategic Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-15,500
| Closed | -$49K | – | 3284 |
|
|
2022
Q2 | $49K | Sell |
15,500
-10,600
| -41% | -$33.5K | ﹤0.01% | 2146 |
|
|
2022
Q1 | $112K | Buy |
26,100
+10,400
| +66% | +$44.6K | ﹤0.01% | 2139 |
|
|
2021
Q4 | $73K | Hold |
15,700
| – | – | ﹤0.01% | 1851 |
|
|
2021
Q3 | $62K | Sell |
15,700
-800
| -5% | -$3.16K | ﹤0.01% | 1901 |
|
|
2021
Q2 | $71K | Buy |
16,500
+300
| +2% | +$1.29K | ﹤0.01% | 1815 |
|
|
2021
Q1 | $68K | Buy |
+16,200
| New | +$68K | ﹤0.01% | 1661 |
|
|
2018
Q1 | – | Sell |
-32,703
| Closed | -$1.05M | – | 1073 |
|
|
2017
Q4 | $1.05M | Buy |
+32,703
| New | +$1.05M | 0.09% | 300 |
|
|
2017
Q3 | – | Sell |
-7,255
| Closed | -$216K | – | 866 |
|
|
2017
Q2 | $216K | Buy |
7,255
+73
| +1% | +$2.17K | 0.02% | 540 |
|
|
2017
Q1 | $214K | Buy |
+7,182
| New | +$214K | 0.02% | 537 |
|